University of New Mexico, College of Pharmacy, Albuquerque, NM.
Adv Chronic Kidney Dis. 2019 Jan;26(1):61-71. doi: 10.1053/j.ackd.2018.10.006.
Infections are an important cause of morbidity and mortality among patients with chronic kidney disease. Therefore, appropriate antibiotic dosing is imperative to achieve positive patient outcomes while minimizing antibiotic dose-related toxicity. Accurately assessing renal function and determining the influence of renal replacement therapy on antibiotic clearance makes drug dosing in this patient population challenging. Furthermore, as technological advances in hemodialysis and peritoneal dialysis occur, research incorporating newer dialysis parameters to guide drug dosing may not be readily available. Currently, there are limited data to guide drug dosing in the setting of automated peritoneal dialysis, short daily hemodialysis, and nocturnal hemodialysis. Antibiotic-dosing recommendations should be carefully evaluated considering the accuracy of the renal function assessment, the similarity of the operating characteristics of the renal replacement therapy studied compared with those being used, and whether the dosing strategy takes advantage of the pharmacodynamic profile of the antibiotic under consideration. After implementing the antibiotic-dosing regimen, therapeutic drug monitoring should occur when possible along with careful monitoring for antibiotic efficacy and safety.
感染是慢性肾脏病患者发病率和死亡率的重要原因。因此,为了获得积极的患者治疗效果,同时将抗生素剂量相关毒性降到最低,给予适当的抗生素剂量至关重要。准确评估肾功能并确定肾脏替代疗法对抗生素清除率的影响使得为该患者人群进行药物剂量调整具有挑战性。此外,随着血液透析和腹膜透析技术的进步,研究纳入新的透析参数来指导药物剂量可能无法轻易获得。目前,在自动化腹膜透析、短时间每日血液透析和夜间血液透析中,指导药物剂量的相关数据有限。在考虑到肾功能评估的准确性、所研究的肾脏替代疗法的操作特性与正在使用的疗法的相似性,以及该剂量策略是否利用了所考虑的抗生素的药效学特征的情况下,应对抗生素剂量建议进行仔细评估。在实施抗生素剂量方案后,应尽可能进行治疗药物监测,并密切监测抗生素的疗效和安全性。